TAG:
laboratories
Part II: Path Condo Labs As A Threat to Pathology
By Robert Michel | From the Volume XI No. 11 – August 9, 2004 Issue
SPECIALIST PHYSICIAN GROUPS are taking active steps to capture anatomic pathology (AP) revenues that result from specimens generated by their groups’ patients. Yet the anatomic pathology profession is only now awakening to this threat. To educate and alert pathologists and their group practice adm…
LabCorp’s Smith Speaks On New Pathology Trend
By Robert Michel | From the Volume XI No. 11 – August 9, 2004 Issue
CEO SUMMARY: During the past decade, Laboratory Corporation of America’s Brad Smith faced the spear point of evolving Medicare/Medicaid compliance initiatives which changed so many laboratory industry business practices. Smith believes that business models for in-house anatomic patholog…
AP Test Over-Utilization Will Be One Achilles’ Heel
By Robert Michel | From the Volume XI No. 11 – August 9, 2004 Issue
CEO SUMMARY: Over-utilization is likely to be a prime concern when federal healthcare enforcers eventually investigate in-house anatomic pathology laboratories owned by specialist physicians. Some in-house pathology lab condo promoters are basing financial performance on 100% utilization …
Exposed: Who Created Path Lab Condo Scheme
By Robert Michel | From the Volume XI No. 11 – August 9, 2004 Issue
CEO SUMMARY: It wasn’t pathologists and it wasn’t laboratory executives who started this scheme. Anatomic pathology condominium laboratory complexes were conceived by urologists in Florida. Some Texas urologists jumped on the bandwagon early, becoming enthusiastic promoters of the sch…
Ex-UroCor Execs Face Criminal Indictments
By Robert Michel | From the Volume XI No. 10 – July 19, 2004 Issue
CEO SUMMARY: Criminal charges filed against ex-UroCor executives center around several marketing practices that have much in common with marketing strategies used by many lab- oratories today. These include discounted pricing for non-Medicare specimens, offering to waive charges to payers…
UroCor’s Sales Tactics Violated Medicare Laws
By Robert Michel | From the Volume XI No. 10 – July 19, 2004 Issue
CEO SUMMARY: By issuing a multi-count criminal indictment against three former UroCor executives, one federal attorney is creating new legal precedents for the laboratory industry. The criminal charges accuse UroCor of inducing physicians through such gambits as deeply-discounted pricing …
Lawyer Argues: UroCor Charges Are a Concern
By Robert Michel | From the Volume XI No. 10 – July 19, 2004 Issue
CEO SUMMARY: Criminal charges in the case against three ex-UroCor executives will likely alter existing compliance practices that affect how a lab offers price discounts to physicians and the way a lab uses “waiver of charges” in situations where it is an out-of-network provider. Atto…
Linking UroCor Indictments With Specialist Doc Pathology
By Robert Michel | From the Volume XI No. 10 – July 19, 2004 Issue
IS THE TIMING of the criminal indictments of three ex-UroCor executives going to be a fortuitous event for the anatomic pathology profession? I ask this question because the exploding trend of specialist physician groups internalizing anatomic pathology services was slated to be the…
Urology & GI Physicians Bring Pathology In-House
By Robert Michel | From the Volume XI No. 10 – July 19, 2004 Issue
CEO SUMMARY: Increasing numbers of urology and gastroenterology specialist groups are deciding to bring anatomic pathology services in-house. This phenomenon has gathered speed during the past year and is becoming a threat to the long-term financial and clinical stability of the anatomic …
Pathology “Condo Labs” Are New Business Ploy
By Robert Michel | From the Volume XI No. 10 – July 19, 2004 Issue
CEO SUMMARY: We call ‘em pathology condominium laboratories. Other names are “pod labs” and “salon labs.” Whatever name is used, this new scheme by specialist physicians to capture pathology revenues may be the most significant threat to the anatomic pathology profession since t…
CURRENT ISSUE

Volume XXXII, No. 13 – September 15, 2025
The Dark Report examines a new bill that would reform PAMA and avoid reimbursement rate cuts scheduled for January 2026. Clinical laboratory leaders are urged to make their voices heard in Congress. Also, an expert describes how labs can fix pre-analytical errors and avoid disaster.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized